StockNews.AI
CTKB
StockNews.AI
117 days

Cytek Biosciences to Report First Quarter 2025 Financial Results on May 8, 2025

1. CTKB to announce Q1 2025 financial results on May 8, 2025. 2. Management will host a conference call post-announcement to discuss results and outlook. 3. Cytek specializes in advanced cell analysis technology, enhancing analysis precision. 4. Company emphasizes dual use in research and clinical settings for certain products. 5. Investors encouraged to monitor multiple channels for operational updates.

Earnings
-1.31%Current Return
VS
+0.73%S&P 500
$3.8204/24 04:15 PM EDTEvent Start
$3.7704/25 10:44 PM EDTLatest Updated
5m saved
Insight
Article

FAQ

Why Bullish?

Upcoming Q1 results may show improved financial performance, which is often positively received by investors.

How important is it?

The scheduled earnings report can significantly impact investor confidence and stock price.

Why Short Term?

The May 8 announcement will create immediate investor interest and market activity.

Related Companies

AXSMPRVBCDMO
April 24, 2025 16:05 ET  | Source: Cytek Biosciences, Inc. FREMONT, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), today announced it will report financial results for the first quarter 2025 after market close on Thursday, May 8, 2025. The company’s management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its results, business developments and outlook. Live audio of the webcast will be available on the “Investors” section of the company website at investors.cytekbio.com About Cytek Biosciences, Inc.Cytek Biosciences (Nasdaq: CTKB) is a leading cell analysis solutions company advancing the next generation of cell analysis tools by delivering high-resolution, high-content, and high-sensitivity cell analysis utilizing its patented Full Spectrum Profiling™ (FSP™) technology. Cytek’s novel approach harnesses the power of information within the entire spectrum of a fluorescent signal to achieve a higher level of multiplexing with precision and sensitivity. Cytek’s platform includes: its core FSP instruments, the Cytek Aurora™ and Northern Lights™ systems and the Cytek Aurora CS cell sorter; the Cytek Orion™ reagent cocktail preparation system; the Enhanced Small Particle™ (ESP™) detection technology; the flow cytometer and imaging products under the Amnis® and Guava® brands; and reagents, software and service to provide a comprehensive and integrated suite of solutions for its customers. Cytek is headquartered in Fremont, California with offices and distribution channels across the globe. More information about the company and its products is available at www.cytekbio.com. Cytek’s products are for research use only and not for use in diagnostic procedures (other than Cytek’s Northern Lights-CLC system and certain reagents, which are available for clinical use in China and the European Union). Cytek, Full Spectrum Profiling, FSP, Cytek Aurora, Northern Lights, Cytek Orion, Enhanced Small Particle, ESP, Amnis and Guava are trademarks of Cytek Biosciences, Inc. In addition to filings with the Securities and Exchange Commission (SEC), press releases, public conference calls and webcasts, Cytek uses its website (www.cytekbio.com), LinkedIn page and X (formerly Twitter) account as channels of distribution of information about its company, products, planned financial and other announcements, attendance at upcoming investor and industry conferences and other matters. Such information may be deemed material information and Cytek may use these channels to comply with its disclosure obligations under Regulation FD. Therefore, investors should monitor Cytek’s website, LinkedIn page, and X account in addition to following its SEC filings, news releases, public conference calls and webcasts. Media Contact:Stephanie OlsenLages & Associates(949) 453-8080stephanie@lages.com Investor Contact:Paul GoodsonHead of Investor RelationsCytek Biosciencespgoodson@cytekbio.com 

Related News